Nabi Biopharmaceuticals (NABI)

They’re eating their own dog food, the Foolish CAPs are set in their direction, and even stockGuru has a fairly close re-entry point today. But NABI’s sudden climb to a new level in November 2009 has me concerned. Still, it has potential, so setting a paranoid limit buy at 5.04

Invest in your karma by sharing this if you found it valuable

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.